Meeting
2017 Genitourinary Cancers Symposium
Circulating tumor (ct)-DNA alterations in metastatic castration-resistant prostate cancer (mCRPC): Association with outcomes and evolution with therapy.
Authors
Guru Sonpavde
University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL
Guru Sonpavde , Rebecca J Nagy , A. Oliver Sartor , Gregory Russell Pond , Theodore Stewart Gourdin , Lakshminarayanan Nandagopal , Elisa M. Ledet , Neeraj Agarwal , Emma Carroll , Gurudatta Naik , Jue Wang , Mehmet Asim Bilen , Petros Grivas , Richard B. Lanman , AmirAli Talasaz , Michael B. Lilly
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Advanced Disease
Citation
J Clin Oncol 35, 2017 (suppl 6S; abstract 149)
DOI
10.1200/JCO.2017.35.6_suppl.149
Abstract #
149
Poster Bd #
F3
Abstract Disclosures
Similar Posters
Poster
2017 Genitourinary Cancers Symposium
Circulating tumor (ct)-DNA alterations in advanced urothelial carcinoma: Association with outcomes and evolution with therapy.
First Author: Petros Grivas
Poster
2019 Gastrointestinal Cancers Symposium
Genomic alterations in appendiceal carcinoma using circulating DNA.
First Author: Walid Labib Shaib
Poster
2016 ASCO Annual Meeting
Circulating cell-free DNA profiling of patients with advanced urothelial carcinoma of the bladder.
First Author: Rebecca J Nagy
Poster
2023 ASCO Annual Meeting
Liquid-biopsy detection of FGFR2 and other actionable rearrangements in GI malignancies.
First Author: Pashtoon Murtaza Kasi